Home Newsfeeds OTR Global Downgrades Tandem Diabetes Care to Mixed

OTR Global Downgrades Tandem Diabetes Care to Mixed

OTR Global downgrades Tandem Diabetes Care (NASDAQ:TNDM) from Positive to Mixed.

byBenzinga Newsdesk

September 7, 2022

1 minute read

OTR Global downgrades Tandem Diabetes Care (NASDAQ:TNDM) from Positive to Mixed.

Recap: Rollins Q2 Earnings

By Benzinga Insights

July 27, 7:58 AM

Rollins (NYSE:ROL) reported its Q2 earnings results on Wednesday, July 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Rollins reported in-line EPS of $0.2 versus an estimate of $0.2.

ROL

Earlier Health Canada Approves Pfizer Canada’s Gene Therapy In Hemophilia B

By Benzinga Newsdesk

January 3, 10:14 AM

Pfizer Canada ULC announced that Health Canada approved BEQVEZ (fidanacogene elaparvovec), an adeno-associated viral (AAV) vector-based gene therapy for the treatment of adults (aged 18 years or older) with moderately

PFE

AMD Says The PC Market Weakened Significantly In The Quarter

By Benzinga Newsdesk

October 6, 4:19 PM

“The PC market weakened significantly in the quarter,” said AMD Chair and CEO Dr. Lisa Su. “While our product portfolio remains very strong, macroeconomic conditions drove lower than expected PC demand

AMD

Dow Rises 75 Points; Kura Sushi USA Shares Spike Higher

By Lisa Levin

July 8, 2:42 PM

U.S. stocks traded slightly higher toward the end of trading as investors digested the recent jobs report for the month of June.

ADTX

OTR Global Downgrades Tandem Diabetes Care to Mixed

Related Posts

Recap: Rollins Q2 Earnings

Earlier Health Canada Approves Pfizer Canada’s Gene Therapy In Hemophilia B

AMD Says The PC Market Weakened Significantly In The Quarter

Dow Rises 75 Points; Kura Sushi USA Shares Spike Higher